PGT/PGD/PGS Cyprus: Helping You Achieve Your Dream Family
At EuroCARE IVF, we understand that building a family is a deeply personal journey. We’re here to offer compassionate, expert guidance on every step, including medical gender selection, allowing individuals and couples to fulfill their uniquely personal family dreams.
What is PGT?
Preimplantation Genetic Testing (PGT) is an advanced laboratory technique used during IVF to analyze embryos before transfer. Embryos are created in the laboratory and carefully examined to assess chromosomal health and, when medically appropriate, determine biological sex. This allows doctors to make informed decisions that prioritize embryo health, accuracy, and successful outcomes.
This method is often used for:
- Family balancing
- Avoiding sex-linked genetic conditions
- Improving embryo selection and IVF outcomes
Unlike outdated or non-medical approaches, PGT provides precise, laboratory-based insight — allowing decisions to be made with confidence and medical oversight.
How PGT Relates to PGD and PGS
PGT is the umbrella term used to describe genetic testing of embryos during IVF. PGD and PGS refer to specific types of testing that fall within this broader PGT process. PGS, now commonly referred to as PGT-A, focuses on screening embryos for chromosomal balance, while PGD, also known as PGT-M, is used to test for specific inherited genetic conditions. Together, these tests allow doctors to gain valuable genetic information that supports informed embryo selection and personalized care.
How Does It Work? Preimplantation Genetic Testing (PGT)
During the PGT process, embryos are developed in the laboratory as part of IVF. A small number of cells are carefully biopsied from the embryo at an appropriate stage of development and analyzed in a specialized genetics laboratory. Once results are available, embryos with healthy chromosomal profiles may be selected for transfer, based on medical guidance and patient preferences.
PGT can be used to screen embryos for chromosomal conditions and, when appropriate, identify specific genetic variations. In many cases, testing focuses on chromosomes commonly associated with genetic conditions, such as chromosomes 13, 18, and 21, which are linked to conditions including Down syndrome, Edwards syndrome, and other chromosomal differences. When clinically indicated, expanded testing may also be performed to assess additional chromosomes or specific genetic mutations.
Benefits of PGT Testing:
- Improved IVF Outcomes: By identifying embryos with balanced chromosomal profiles, PGT can support higher implantation rates and increase the chances of a successful pregnancy.
- Informed Medical Gender Selection: PGT in Cyprus is 99.9% accurate in identifying chromosomal abnormalities and determining the gender of embryos.
- Health and Safety: Reduces risks of genetic disorders, ensuring the health of your future child.
Who May Benefit From PGT?
PGT may be considered for individuals or couples who want additional genetic insight as part of their IVF journey, including:
- Women over 35 years of age
- Couples who have experienced several spontaneous miscarriages of unknown cause
- Couples with several cycles of IVF that have not achieved pregnancy
- Men with low sperm concentration
- Couples with a previous pregnancy with chromosomal abnormality
Why Choose EuroCARE IVF?
- Compassionate Care: Our patient-first approach ensures you feel supported every step of the way.
- Affordability: Check out our IVF Packages for competitive IVF costs without compromising on quality.
- Expertise and Trust: Recognized for excellence, EuroCARE IVF is a trusted choice for PGT-A in Cyprus and beyond.
By choosing EuroCARE IVF, you’re selecting a facility with proven expertise in PGT technology, where every step is handled with precision, care, and confidentiality. Start your journey with us today and explore the possibilities of PGT IVF in a comforting, affordable, expert-driven environment.
Frequently Asked Questions About PGT-A IVF in Cyprus
Medical gender selection refers to choosing the sex of an embryo for medical reasons, not for family balancing or personal preference. EuroCARE IVF uses advanced genetic screening to ensure embryos are healthy before implantation.
Yes, Cyprus is one of the few countries where medical gender selection is legally permitted for medical reasons.
Gender selection is performed through PGT, which boasts an accuracy rate of over 99% for identifying embryo chromosome. Combined with EuroCARE’s high embryology standards, this results in a highly reliable and safe method of screening that does not compromise embryo health.
Absolutely. PGT can be performed on embryos created from both donor and partner gametes. This allows same-sex couples, single parents, or those with fertility challenges to pursue family.
In many cases, PGT-A can improve overall IVF outcomes by identifying the most viable embryos, reducing miscarriage risk, and improving implantation rates. Selecting embryos that are both chromosomally normal gives patients a better chance at a successful pregnancy.
If you complete the hormone stimulation and testing in your home country, your stay in Cyprus can be as short as 9 days. This includes embryo transfer and follow-up. EuroCARE provides travel and treatment coordination to help minimize time abroad while maximizing efficiency.
Yes. Because PGT-A testing requires embryo biopsy, laboratory analysis, and advanced embryology support, the total cost of PGT-A is higher than standard IVF. However, EuroCARE offers fixed-price packages that include all relevant services to help patients budget with confidence.